JACKSON, SIMON
JACKSON, SIMON
SPS - DIPARTIMENTO DI SCIENZE POLITICHE E SOCIALI
Personale esterno ed autonomi
Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study
2026 Olasupo, O. O.; Iserman, E.; Keepanasseril, A.; Ibrahim, Q.; Ali Al-Housni, Z. S.; Germini, F.; Tarride, J. -E.; Mbuagbaw, L.; Jackson, S.; Blydt-Hansen, I.; Bech, M.; Woo, C.; Belletrutti, M.; Iorio, A.; Matino, D.; Khalife, R.; Brose, K.; Malcolmson, C.; Uminski, K.; Amid, A.; Moorehead, P.; St-Louis, J.; Vezina, C.; Leung, J.; Serebrin, A.; Pelland-Marcotte, M. -C.; Tole, S.; Harrigan, A.; Steele, M.; Sinha, R.; Carcao, M.; Chan, A. K. C.; Phua, C. W.; Klaassen, R.; Poon, M. -C.
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
2026 Pierce, G. F.; Ozelo, M. C.; Mahlangu, J.; Dunn, A. L.; Beijlevelt, M.; Bender, R.; Carcao, M.; Coffin, D.; Grazzi, E. F.; Foster, G. R.; Frantsve-Hawley, J.; Iorio, A.; Jackson, S.; Kaczmarek, R.; Kaeser, G. E.; Konkle, B. A.; Lewandowska, M.; Miesbach, W.; O'Mahony, B.
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes
2021 Sun, H.; Yang, M.; Poon, M. -C.; Lee, A.; Robinson, K. S.; Sholzberg, M.; Wu, J.; Iorio, A.; Blanchette, V.; Carcao, M.; Klaassen, R. J.; Jackson, S.
Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set
2021 Van Balen, E. C.; O'Mahony, B.; Cnossen, M. H.; Dolan, G.; Blanchette, V. S.; Fischer, K.; Gue, D.; O'Hara, J.; Iorio, A.; Jackson, S.; Konkle, B. A.; Nugent, D. J.; Coffin, D.; Skinner, M. W.; Smit, C.; Srivastava, A.; Van Eenennaam, F.; Van Der Bom, J. G.; Gouw, S. C.
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
2021 Sun, H.; Yang, M.; Poon, M. -C.; Lee, A.; Robinson, K. S.; Sholzberg, M.; Wu, J.; Iorio, A.; Blanchette, V.; Carcao, M.; Klaassen, R. J.; Jackson, S.
Switching to extended half‐life products in Canada – preliminary data
2017 Keepanasseril, A.; Stoffman, J.; Bouskill, V.; Carcao, M.; Iorio, A.; Jackson, S.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study | Olasupo, O. O.; Iserman, E.; Keepanasseril, A.; Ibrahim, Q.; Ali Al-Housni, Z. S.; Germini, F.; T...arride, J. -E.; Mbuagbaw, L.; Jackson, S.; Blydt-Hansen, I.; Bech, M.; Woo, C.; Belletrutti, M.; Iorio, A.; Matino, D.; Khalife, R.; Brose, K.; Malcolmson, C.; Uminski, K.; Amid, A.; Moorehead, P.; St-Louis, J.; Vezina, C.; Leung, J.; Serebrin, A.; Pelland-Marcotte, M. -C.; Tole, S.; Harrigan, A.; Steele, M.; Sinha, R.; Carcao, M.; Chan, A. K. C.; Phua, C. W.; Klaassen, R.; Poon, M. -C. | 2026-01-01 | RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | - | 1.01 Articolo in rivista | PIIS2475037925006041.pdf; mmc1 (2).docx |
| The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 | Pierce, G. F.; Ozelo, M. C.; Mahlangu, J.; Dunn, A. L.; Beijlevelt, M.; Bender, R.; Carcao, M.; C...offin, D.; Grazzi, E. F.; Foster, G. R.; Frantsve-Hawley, J.; Iorio, A.; Jackson, S.; Kaczmarek, R.; Kaeser, G. E.; Konkle, B. A.; Lewandowska, M.; Miesbach, W.; O'Mahony, B. | 2026-01-01 | HAEMOPHILIA | - | 1.01 Articolo in rivista | - |
| Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes | Sun, H.; Yang, M.; Poon, M. -C.; Lee, A.; Robinson, K. S.; Sholzberg, M.; Wu, J.; Iorio, A.; Blan...chette, V.; Carcao, M.; Klaassen, R. J.; Jackson, S. | 2021-01-01 | HAEMOPHILIA | - | 1.01 Articolo in rivista | - |
| Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set | Van Balen, E. C.; O'Mahony, B.; Cnossen, M. H.; Dolan, G.; Blanchette, V. S.; Fischer, K.; Gue, D....; O'Hara, J.; Iorio, A.; Jackson, S.; Konkle, B. A.; Nugent, D. J.; Coffin, D.; Skinner, M. W.; Smit, C.; Srivastava, A.; Van Eenennaam, F.; Van Der Bom, J. G.; Gouw, S. C. | 2021-01-01 | RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | - | 1.01 Articolo in rivista | - |
| The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B | Sun, H.; Yang, M.; Poon, M. -C.; Lee, A.; Robinson, K. S.; Sholzberg, M.; Wu, J.; Iorio, A.; Blan...chette, V.; Carcao, M.; Klaassen, R. J.; Jackson, S. | 2021-01-01 | RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | - | 1.01 Articolo in rivista | - |
| Switching to extended half‐life products in Canada – preliminary data | Keepanasseril, A.; Stoffman, J.; Bouskill, V.; Carcao, M.; Iorio, A.; Jackson, S. | 2017-01-01 | HAEMOPHILIA | - | 1.01 Articolo in rivista | - |